Works matching IS 15268209 AND DT 2024 AND VI 24 AND IP 5


Results: 10
    1
    2
    3
    4

    The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.

    Published in:
    Clinical Breast Cancer, 2024, v. 24, n. 5, p. 421, doi. 10.1016/j.clbc.2024.02.012
    By:
    • Debien, Veronique;
    • Agostinetto, Elisa;
    • Bruzzone, Marco;
    • Ceppi, Marcello;
    • Martins-Branco, Diogo;
    • Molinelli, Chiara;
    • Jacobs, Flavia;
    • Nader-Marta, Guilherme;
    • Lambertini, Matteo;
    • de Azambuja, Evandro
    Publication type:
    Article
    5
    6
    7
    8
    9
    10